Effect of nitric oxide donors on uterine and sub-endometrial blood flow in patients with unexplained infertility: a randomized controlled trial
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20212144Keywords:
Unexplained, Infertility, Nitric oxide, Nitroglycerine, Doppler, Sub-endometrialAbstract
Background: Impaired sub-endometrial perfusion might reduce endometrial receptivity and possibly contribute to unexplained infertility. A favorable effect on sub-endometrial blood flow has been demonstrated with nitric oxide.
Methods: This randomized controlled trial evaluated the effect of nitroglycerine on uterine and sub-endometrial blood flow in women with unexplained infertility. Sixty women were randomized into 2 equal groups. The study group received 5mg nitroglycerine patch daily from day 2 of the cycle till the evaluation day and the control group received no treatment. Independent of the study arms, 30 parous women were included as the fertile group. Six to eight days after detecting luteinizing hormone surge, women were assessed for endometrial thickness, uterine artery blood flow with color Doppler and sub-endometrial blood flow with three-dimensional power Doppler.
Results: Compared to fertile women, cases with unexplained infertility (control group) had a significantly thinner endometrium, higher uterine artery Doppler indices and lower sub-endometrial blood flow. Women who received nitroglycerin showed a significant improvement in sub-endometrial blood flow while uterine artery blood flow did not show a significant difference; however, the values were also comparable to fertile women. In addition, no effect on endometrial thickness was found with nitroglycerin treatment. Nitroglycerin treatment side effects were headache, blurring of vision and hypotension. These adverse effects were not significant compared to controls.
Conclusions: In women with unexplained infertility, nitroglycerin significantly improved the sub-endometrial blood flow but did not affect the endometrial thickness.
Metrics
References
American Society of Reproductive Medicine. Evidence-based treatments for couples with unexplained infertility: a guideline. Fertil Streril. 2020;113(2):305-22.
Kupesic S, Bekavac I, Bjelos D, Kurjak A. Assessment of endometrial receptivity by transvaginal color Doppler and three-dimensional power Doppler ultrasonography in patients undergoing in vitro fertilization procedures. J Ultrasound Med. 2001;20(2):125-34.
Elnaggar A, Farag AH, Gaber M, Hafeez MA, Ali MS, Atef AM. AlphaVBeta3 Integrin expression within uterine endometrium in unexplained infertility: a prospective cohort study. BMC Womens Health. 2017;17(1):90.
Craciunas L, Gallos I, Chu J, Bourne T, Quenby S, Brosens JJ, Coomarasamy A. Conventional and modern markers of endometrial receptivity: a systematic review and meta-analysis. Hum Reprod Update. 2019;25(2):202-23.
Kim A, Jung H, Choi WJ, Hong SN, Kim HY. Detection of endometrial and sub-endometrial vasculature on the day of embryo transfer and prediction of pregnancy during fresh in vitro fertilization cycles. Taiwan J Obstet Gynecol. 2014;53(3):360-65.
Wang L, Shulan LV, Mao W, Pei M, Yang X. Assessment of endometrial receptivity during implantation window in women with unexplained infertility. Gynecol Endocrinol. 2020.
Kim A, Han JE, Yoon TK, Lyu SW, Seok HH, Won HJ. Relationship between endometrial and sub-endometrial blood flow measured by three-dimensional power Doppler ultrasound and pregnancy after intrauterine insemination. Fertil Steril. 2010;94(2):747-52.
Zebitay AG, Tutumlu M, Verit FF, Ilhan GK, Gungor ES, Cetin O et al. A comparative analysis of arterial blood flow in unexplained infertility, tubal infertility and fertile groups. Gynecol Endocrinol. 2016;32(6):442-5.
Mörlin B, Hammarström M. Nitric oxide increases endocervical secretion at the ovulatory phase in the female. Acta Obstet Gynecol Scand. 2005;84(9):883-6.
Dubey PK, Tripathi V, Singh RP, Saikumar G, Nath A, Pratheesh Gade N et al. Expression of nitric oxide synthase isoforms in different stages of buffalo (Bubalus bubalis) ovarian follicles: effect of nitric oxide on in vitro development of preantral follicle. Theriogenology. 2012;77(2):280-91.
Hefler LA, Gregg AR. Inducible and endothelial nitric oxide synthase: genetic background affects ovulation in mice. Fertil Steril. 2002;77(1):147-51.
Zamberlam G, Sahmi F, Price CA. Nitric oxide synthase activity is critical for the preovulatory epidermal growth factor-like cascade induced by luteinizing hormone in bovine granulosa cells. Free Radic Biol Med. 2014;74:237-44.
Van Buren GA, Yang DS, Clark KE. Estrogen-induced uterine vasodilatation is antagonized by L-nitroarginine methyl ester, an inhibitor of nitric oxide synthesis. Am J Obstet Gynecol. 1992;167(3):828-33.
Abdel Razik M, El-Berry S, El-Nezamy A, Saad A, Abdel Wahab A. Nitric oxide donors increase the pregnancy rate in patients with unexplained infertility undergoing clomiphene citrate stimulation and intrauterine insemination: a randomized controlled pilot study. Gynecol Endocrinol. 2016.
Fetih AN, Habib DM, Abdelaal II, Hussein M, Fetih GN, Othman ER. Adding sildenafil vaginal gel to clomiphene citrate in infertile women with prior clomiphene citrate failure due to thin endometrium: a prospective self-controlled clinical trial. Facts Views Vis Obgyn. 2017;9(1):21-7.
El-Mazny A, Abou-Salem N, ElShenoufy H. Doppler study of uterine hemodynamics in women with unexplained infertility. European J Obstet Gynecol Reprod Biol. 2013;171(2013):84-7.
El-Zenneni H, Moustafa R, Abdel-Hafeez M, El-Salally H, Abdel-Kader A, Elnaggar A. Assessment of uterine, subendometrial blood flows and endometrial gland vascular endothelial growth factor (EG-VEGF) in women with unexplained infertility. Middle East Fertil Soc J. 2015;20:119-26.
Uysal S, Ozbay EP, Ekinci T, Aksüt H, Karasu S, Işık AZ et al. Endometrial spiral artery Doppler parameters in unexplained infertility patients: is endometrial perfusion an important factor in the etiopathogenesis? J Turk Ger Gynecol Assoc. 2012;13(3):169-71.
Chen M, He Y, Zhang P, Geng Q, Liu Q, Kong L et al. comparison of uterine receptivity between fertile and unexplained infertile women by assessment of endometrial and subendometrial perfusion using contrast-enhanced ultrasound: which index is better – peak intensity or area under the curve? Ultrasound in Med Biol. 2016;42(3):654-63.
Hashad A, Ibrahim I, Etman M, Elkholy H. A Study of Endometrial Perfusion in Unexplained Infertility. The Egyptian J Hospital Med. 2018;72(6):4673-80.
Ibrahim AM, El-Mandooh M, Fathy H, Alhariri HA. Ovarian and Uterine Blood Flow Indices in Patients with Unexplained Infertility Undergoing ICSI and their Relation to Clinical Pregnancy Rate. EBWHJ. 2020;10(3):188-200.
Schild RL, Holthanus S, d’Alquen J, Fimmers R, Dorn C, van der Ven H et al. Quantitative assessment of subendometrial blood flow by three-dimensional-ultrasound is an important predictive factor of implantation in an in-vitro fertilization programme. Hum Reprod. 2000;15(1):89-94.
Ohl J, Lefèbvre-Maunoury C, Wittrmer C, Nisand G, Laurent M, Hoffmann P. nitric oxide donors for patients undergoing IVF. A prospective, double-blind, randomized, placebo-controlled trial. Human Reprod. 2002;17(10):2615-20.
Farzi F, Mehrafza M, Mirmansouri A, Oudi M, Hoseeini A. Administration of NTG before embryo transfer does not increase pregnancy rate. IJRM. 2005;3(2):95-100.
Edi-Osagie E, Seif M, Aplin J, Jones C, Wilson G, Lieberman B. Characterizing the endometrium in unexplained and tubal factor infertility: a multiparametric investigation. Fertil Steril. 2004;82:1379-89.
Aboelroose A, Ibrahim A, Madny E, Elmazzahy A, Taha O. A randomized clinical trial of sildenafil plus clomiphene citrate to improve the success rate of ovulation induction in patients with unexplained infertility. Int J Gynecol Obstet. 2020;150:72-6.
Hamid AMA, Elbiaa AMA Saadoun RA, Rateb A, Madkour WAI. Effect of Adding Sildenafil to Clomiphene Citrate versus Clomiphene Citrate alone on Endometrium in Unexplained Infertility: Cross-Sectional, Non-Randomized Study. Obstet Gynecol Int J. 2017;7(2):00243.
Battaglia C, Salvatori M, Maxia N, Petraglia F, Facchinetti F, Volpe A. Adjuvant L-arginine treatment for in-vitro fertilization in poor responder patients. Hum Reprod. 1999;14(7):1690-7.
Battaglia C, Regnani G, Marsella T, Facchinetti F, Volpe A, Venturoli S et al. Adjuvant L-arginine treatment in controlled ovarian hyperstimulation: a double-blind, randomized study. Hum Reprod. 2002;17(3):659-65.
Bahaa HA. Efficacy of sildenafil citrate in women with unexplained recurrent miscarriage preconceptional and during 1st trimester of pregnancy. EBWHJ. 2018;8(1):138-44.
Abdel Razik M, El-Berry S, Mostafa A. The effects of nitric oxide donors on uterine artery and sub-endometrial blood flow in patients with unexplained recurrent abortion. J Reprod Infertil. 2014;15(3):142-6.
Amin AF, Shaaban OM, Bediway MA. N-acetyl cysteine for treatment of recurrent unexplained pregnancy loss. Reprod Biomed Online. 2008;17(5):722-6.
Gutarra-Vilchez RB, Bonfill Cosp X, Glujovsky D, Viteri-García A, Runzer-Colmenares FM, Martinez-Zapata MJ. Vasodilators for women undergoing fertility treatment. Cochrane Database Systematic Reviews. 2018;10;CD010001.
Fang R, Cai L, Xiong F, Chen J, Yang W, Zhao X. The effect of endometrial thickness on the day of hCG administration on pregnancy outcome in the first fresh IVF/ICSI cycle. Gynecol Endocrinol. 2016;32(6):473-6.
Eftekhar M, Mehrjardi S, Molaei B, Taheri F, Mangoli E. The correlation between endometrial thickness and pregnancy outcomes in fresh ART cycles with different age groups: a retrospective study. Middle East Fertil Soc J. 2019;24:10.
He L, Zhanga Z, Li H, Li Y, Long L, He W. Correlation between endometrial thickness and perinatal outcome for pregnancies achieved through assisted reproduction technology. J Perinat Med. 2019;aop.
Singh N, Bahadur A, Mittal S, Malhotra N, Bhatt A. Predictive value of endometrial thickness, pattern and sub-endometrial blood flows on the day of hCG by 2D Doppler in in-vitro fertilization cycles: A prospective clinical study from a tertiary care unit. J Hum Reprod Sci. 2011;4(1):29-33.
